Fungicidal compounds and compositions
US-2016235070-A1 · Aug 18, 2016 · US
US2016374344A9 · US · A9
| Field | Value |
|---|---|
| Publication number | US-2016374344-A9 |
| Application number | US-201514690929-A |
| Country | US |
| Kind code | A9 |
| Filing date | Apr 20, 2015 |
| Priority date | Jan 30, 2013 |
| Publication date | Dec 29, 2016 |
| Grant date | — |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
This invention is related to the use of a volatile antimicrobial compound against pathogens affecting humans comprising contacting infected areas with an atmosphere containing an effective amount of a volatile antimicrobial compound in gaseous form. The volatile antimicrobial compounds provided include certain oxaborole compounds, for example benzoxaboroles. Delivery systems are provided to take advantage of the volatile nature of these antimicrobial compounds. The method and use disclosed can be combined with other volatile compounds.
Opening claim text (preview).
We claim: 1 . A method of using a volatile antimicrobial compound against pathogens, comprising: contacting areas infected by the pathogens with an atmosphere containing an effective amount of the volatile antimicrobial compound in gaseous form, the volatile antimicrobial compound having a structure of formula (VI): wherein each R is independently hydrogen, alkyl, alkene, alkyne, haloalkyl, haloalkene, haloalkyne, alkoxy, alkeneoxy, haloalkoxy, aryl, heteroaryl, arylalkyl, arylalkene, arylalkyne, heteroarylalkyl, heteroarylalkene, heteroarylalkyne, halogen, hydroxyl, nitrile, amine, ester, carboxylic acid, ketone, alcohol, sulfide, sulfoxide, sulfone, sulfoximine, sulfilimine, sulfonamide, sulfate, sulfonate, nitroalkyl, amide, oxime, imine, hydroxylamine, hydrazine, hydrazone, carbamate, thiocarbamate, urea, thiourea, carbonate, aryloxy, or heteroaryloxy; n=1, 2, 3, or 4; B is boron; X═(CR 2 ) m where m=1, 2, 3, or 4; Y is alkyl, alkene, alkyne, haloalkyl, haloalkene, haloalkyne, alkoxy, alkeneoxy, haloalkoxy, aryl, heteroaryl, arylalkyl, arylalkene, arylalkyne, heteroarylalkyl, heteroarylalkene, heteroarylalkyne, hydroxyl, nitrile, amine, ester, carboxylic acid, ketone, alcohol, sulfide, sulfoxide, sulfone, sulfoximine, sulfilimine, sulfonamide, sulfate, sulfonate, nitroalkyl, amide, oxime, imine, hydroxylamine, hydrazine, hydrazone, carbamate, thiocarbamate, urea, thiourea, carbonate, aryloxy, or heteroaryloxy; with a proviso that R is not aryloxy or heteroaryloxy when Y is hydroxyl; and pharmaceutically or agriculturally acceptable salts thereof. 2 . The method of claim 1 , wherein the areas affected by the pathogens are selected from the group consisting of vaginal yeast infections, athlete's foot, tinea, or combinations thereof. 3 . The method of claim 1 , wherein the pathogens are selected from the group consisting of Candida albicans, C. tropicalis, C. glabrata, C. krusei, C. parapsilosis, C. dubliniensis, C. lusitaniae, Epidermophyton flocoosum, Trichiphyton rubrum, Trichophyton mentagrophytes , or combinations thereof. 4 . The method of claim 1 , further comprising impregnating, microencapsulating, or coating a material for releasing the volatile antimicrobial compound in a gaseous form. 5 . The method of claim 1 , wherein the volatile antimicrobial compound remain in its gaseous form for seven days. 6 . The method of claim 1 , wherein the volatile antimicrobial compound has a structure of 7 . A method of using a volatile antimicrobial compound against pathogens, comprising: (a) mixing a volatile antimicrobial compound with an organic solvent; (b) heating the mixture from step (a) to evaporate the organic solvent and render the volatile antimicrobial compound into its gaseous form; and (c) contacting areas infected by the pathogens with an atmosphere containing an effective amount of the volatile antimicrobial compound in gaseous form at a temperature between 1° C. and 50° C.; wherein the volatile antimicrobial compound having a structure of formula (IV): each R is independently hydrogen, alkyl, alkene, alkyne, haloalkyl, haloalkene, haloalkyne, alkoxy, alkeneoxy, haloalkoxy, aryl, heteroaryl, arylalkyl, arylalkene, arylalkyne, heteroarylalkyl, heteroarylalkene, heteroarylalkyne, halogen, hydroxyl, nitrile, amine, ester, carboxylic acid, ketone, alcohol, sulfide, sulfoxide, sulfone, sulfoximine, sulfilimine, sulfonamide, sulfate, sulfonate, nitroalkyl, amide, oxime, imine, hydroxylamine, hydrazine, hydrazone, carbamate, thiocarbamate, urea, thiourea, carbonate, aryloxy, or heteroaryloxy; n=1, 2, 3, or 4; B is boron; X═(CR 2 ) m where m=1, 2, 3, or 4; Y is alkyl, alkene, alkyne, haloalkyl, haloalkene, haloalkyne, alkoxy, alkeneoxy, haloalkoxy, aryl, heteroaryl, arylalkyl, arylalkene, arylalkyne, heteroarylalkyl, heteroarylalkene, heteroarylalkyne, hydroxyl, nitrile, amine, ester, carboxylic acid, ketone, alcohol, sulfide, sulfoxide, sulfone, sulfoximine, sulfilimine, sulfonamide, sulfate, sulfonate, nitroalkyl, amide, oxime, imine, hydroxylamine, hydrazine, hydrazone, carbamate, thiocarbamate, urea, thiourea, carbonate, aryloxy, or heteroaryloxy; with a proviso that R is not aryloxy or heteroaryloxy when Y is hydroxyl; and pharmaceutically or agriculturally acceptable salts thereof. 8 . The method of claim 7 , wherein the areas affected by the pathogens are selected from the group consisting of vaginal yeast infections, athlete's foot, tinea, or combinations thereof. 9 . The method of claim 7 , wherein the pathogens are selected from the group consisting of Candida albicans, C. tropicalis, C. glabrata, C. krusei, C. parapsilosis, C. dubliniensis, C. lusitaniae, Epidermophyton flocoosum, Trichiphyton rubrum, Trichophyton mentagrophytes , or combinations thereof. 10 . The method of claim 7 , wherein the volatile antimicrobial compound remain in its gaseous form for seven days. 11 . The method of claim 7 , wherein the volatile antimicrobial compound has a structure of 12 . The method of claim 7 , wherein the organic solvent comprise acetone or ethanol. 13 . A method of using a volatile antimicrobial compound against pathogens, comprising: contacting areas infected by the pathogens with an atmosphere containing an effective amount of the volatile antimicrobial compound in gaseous form, the volatile antimicrobial compound having a structure of formula (A1) or (A2): wherein each of A 1 , A 2 , D 1 , and D 2 is independently hydrogen, substituted or unsubstituted C 1-18 -alkyl, arylalkyl, aryl, or heterocyclic; or A 1 and D 1 , or A 2 and D 2 together form a 5, 6, or 7-membered fused ring which is substituted or unsubstituted; each of R 13 , R 16 , R 17 , R 18 , and R 19 is independently hydrogen, substituted or unsubstituted C 1-6 -alkyl, nitrile, nitro, aryl or aryl alkyl; or R 16 and R 17 , or R 18 and R 19 together form an alicyclic ring which is substituted or unsubstituted; B is boron; G is a substituted or unsubstituted C 1-18 -alkylene, arylalkylene, arylene, or heterocyclic moiety; and pharmaceutically or agriculturally acceptable salts thereof. 14 . The method of claim 13 , wherein the areas affected by the pathogens are selected from the group consisting of vaginal yeast infections, athlete's foot, tinea, or combinations thereof. 15 . The method of claim 13 , wherein the pathogens are selected from the group consisting of Candida albicans, C. tropicalis, C. glabrata, C. krusei, C. parapsilosis, C. dubliniensis, C. lusitaniae, Epidermophyton flocoosum, Trichiphyton rubrum, Trichophyton mentagrophytes , or combinations thereof. 16 . The method of claim 13 , further comprising impregnating, microencapsulating, or coating a material for releasing the volatile antimicrobial compound in a gaseous form. 17 . The method of claim 13 , wherein the volatile antimicrobial compound remain in its gaseous form for seven days. 18 .
Biocides, pest repellants or attractants, or plant growth regulators, containing organic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen and sulfur (containing organo-phosphorus compounds A01N57/00) · CPC title
in the form of gases, e.g. fumigation; Compositions or apparatus therefor · CPC title
in a controlled atmosphere comprising other gases in addition to CO2, N2, O2 or H2O {; Elimination of such other gases} · CPC title
Organic compounds; Microorganisms; Enzymes · CPC title
Boron compounds · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.